Adalta

Developing next-generation antibody therapeutics for the treatment of fibrosis and cancer.

placeBundoora, Victoria, Australia calendar_todayFounded 2007 groups12 employees language adalta.com.au

Registered entities

Innovation

7 patent families (3 granted) — focus: Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 820 times.

YearFilings
20121
20142
20162
20171
20181
20191
20201
20211
20221
20232
20253
20261

Social engagement

Social engagement: 2.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Accelerator & incubator133%
Bank & private debt133%

Recent activity

1 Jul 2026
Partnership
Oktopi
30 Jun 2026
Milestone
regulatory
25 Jun 2026
Milestone
regulatory
Coming soon